A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome — Stella

Recruiting

Back to Phelan-McDermid Syndrome trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(3 sites)

United States

Neuren PMS-301 Site#111, San Rafael, California

Neuren PMS-301 Site#109, Chevy Chase, Maryland

Neuren PMS-301 Site#101, New York, New York

Key details

Phase

Large-scale testing

Sponsor

Neuren Pharmaceuticals Limited

Enrollment target

~160 participants

Started

November 2025

Primary completion

October 2027

Age range

3 Years – 12 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov